{
  "name": "Medshield Labs Llc",
  "credentials": "",
  "specialty": "Clinical Laboratory",
  "city": "Dallas",
  "state": "TX",
  "entity_type": "Organization",
  "yearly_payments": [
    {
      "year": 2022,
      "total_payments": 5603.0,
      "total_services": 114,
      "total_beneficiaries": 1,
      "avg_submitted": 100.0,
      "avg_paid": 49.15
    },
    {
      "year": 2023,
      "total_payments": 31542132.51,
      "total_services": 2682157,
      "total_beneficiaries": 1,
      "avg_submitted": 15.56,
      "avg_paid": 11.76
    }
  ],
  "overall": {
    "total_payments": 31547735.51,
    "total_services": 2682271,
    "total_beneficiaries": 2,
    "avg_markup_ratio": 1.32,
    "years_active": 2
  },
  "top_procedures": [
    {
      "code": "K1034",
      "description": "Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count",
      "services": 2682157,
      "payments": 31542132.51,
      "avg_markup": 1.32
    },
    {
      "code": "U0003",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r",
      "services": 57,
      "payments": 4202.25,
      "avg_markup": 2.03
    },
    {
      "code": "U0005",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within",
      "services": 57,
      "payments": 1400.75,
      "avg_markup": 2.03
    }
  ]
}